Serina Therapeutics, Inc.
148.6M
$25.78M
-3.31
$-1.51
No price alerts set. Add an alert to get notified!
-3.31
57.52
$-1.51
-2,193.11%
-19,894.64%
-30,442.86%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ALGS
Aligos Therapeutics, Inc.
|
$7.50 | 7.91% | -3.22 | $46.15M | 0.10 |
|
BRNS
Barinthus Biotherapeutics plc
|
$0.65 | 1.74% | -0.40 | $26.54M | 0.15 |
|
CVM
CEL-SCI Corporation
|
$3.75 | 4.46% | -1.26 | $25.77M | 0.95 |
|
GNTA
Genenta Science S.p.A.
|
$0.65 | -5.80% | -1.21 | $12.44M | 0.62 |
|
GRCE
Grace Therapeutics, Inc.
|
$4.39 | -1.13% | -10.87 | $62.02M | 0.00 |
|
INMB
INmune Bio, Inc.
|
$1.20 | -3.23% | -0.64 | $31.90M | 0.04 |
|
JUNS
Jupiter Neurosciences, Inc.
|
$0.38 | 2.70% | -1.70 | $13.08M | 3.14 |
|
SKYE
Skye Bioscience, Inc.
|
$0.66 | -2.61% | -0.46 | $21.02M | 0.01 |
|
TELO
Telomir Pharmaceuticals, Inc. Common Stock
|
$1.30 | 2.36% | -4.29 | $44.70M | 0.00 |
|
XFOR
X4 Pharmaceuticals, Inc.
|
$4.14 | 2.21% | -2.21 | $47.23M | 0.01 |
* Peer stocks are selected based on market capitalization and sector
$7.92
$1.22
$0.00
0.00%
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
